Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients

Nephron

Volumn 82, Issue 2, 1999, Pages 139-144

  Tomino, Yasuhiko ^a   Makita, Yuichiro ^a   Shike, Toshihide ^a   Gohda, Tomohito ^a   Haneda, Masakazu ^b   Kikkawa, Ryuichi ^b   Watanabe, Tsuyoshi ^c   Baba, Tsuneharu ^d   Yoshida, Hiroaki ^e  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e Tokyo Medical University School of Medicine   (Japan)

Author keywords

Diabetic nephropathy; Gene polymorphism; Renal progression; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; HEMOGLOBIN A1C; PRIMER DNA;

ADULT; AGE; AGED; ALLELE; ARTICLE; BLOOD PRESSURE; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE DURATION; DNA POLYMORPHISM; EYE FUNDUS; FEMALE; GENDER; HUMAN; HUMAN CELL; JAPAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEINURIA; URINARY EXCRETION;

AGED; ANGIOTENSIN II; ANGIOTENSINOGEN; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; DNA; FEMALE; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, ANGIOTENSIN;

EID: 0033030198     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045390     Document Type: Article

References (42)

1. Nelson RG, Knowler WC, Bennet PH: Natural history of diabetic nephropathy in non-insulin-dependent diabetes mellitus. J Diabetes Complications 1991;5:76-78.
2. Hasslacher C, Ritz E, Wahl P, Michael C: Similar risks of nephropathy in patients with type I and type II diabetes mellitus. Nephrol Dial Transplant 1989;4:859-863.
3. Incidence by primary disease in 1997; in: An overview of regular dialysis treatment in Japan. J Jpn Soc Dial Ther, 1997, pp 1-48.
4. Pettit DJ, Saad MF, Bennet PH, Nelson RG, Knowler WC: Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1990;33:438-443.
5. Keller CK, Bergis KH, Riser D, Ritz E: Renal findings in patients with short-term type 2 diabetes. J Am Soc Nephrol 1996;7:2627-2635.
6. Sealey J, Laragh JH: The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis; in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis and Management. New York, Raven Press, 1990, pp 1287-1318.
7. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329:1456-1462.
8. Parving HH, Rossing P, Hommel E, Smidt UM: Angiotensin-converting enzyme inhibition in diabetic nephropathay: Ten years' experience. Am J Kidney Dis 1995;26:99-107.
9. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin-I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
10. Schunkert H, Hense HW, Holmer SR, et al: Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-1638.
11. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L. Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-644.
12. Markus HS, Barley J, Lunt R, Bland JM, Jeffery S, Carter ND, Brown MM: Angiotensin-converting enzyme gene deletion polymorphism: A new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995;26:1329-1333.
13. Bonnardeaux AE, Davies X, Jeunemaitre I, Fery A, Charru E, Clauser L, Tiret F, Cambien P, Corvol F, Soubrier F: Angiotensin II type 1 receptor gene polymorphism in human essential hypertension. Hypertension 1994;24:63-69.
14. Tirte L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Luc G, Kee F, Ducimetiere P, Soubrier F, Cambien F: Synergic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphism on risk of myocardial infarction. Lancet 1994;344:910-913.
15. Kosaka K: Committee report on the diagnosis of diabetes mellitus (in Japanese). Diabetes Sec 1982;25:859-866.
16. Ringel J, Beige J, Kunz R, Distler A, Sharma AM: Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension. Diabetologia 1997;40:193-199.
17. Rigat B, Hubert C, Alhenc Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86: 1343-1346.
18. Lindpaintern K, Pfeffer MA, Krenz R, Stampfer MJ, Grodstein F, Lamotte F, Buring J, Hennekens H: A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-711.
19. Schmidt S, Sharma AM, Zilch O, Beige J, Walla-Friedel M, Ganten D, Distler A, Ritz E: Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. Nephrol Dial Transplant 1995;10: 1145-1148.
20. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura F, Nyengaard JR, Van Den Enden M, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complication. Diabetes 1993;42:801-813.
21. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981;19:410-415.
22. Ruiz J, Blanche H, Cohen N, Veiho G, Cambien F, Cohen D, Passa P, Froguel P: Insertion/ deletion polymorphism of the angiotensin converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994;91:3662-3665.
23. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K: Deletion polymorphism of the angiotensin I converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1995;91: 270-274.
24. Mattu RK, Needham EWA, Galton DJ, Frangos E, Clark AJL, Caulfield M: A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 1995; 91:270-274.
25. Badenhop RF, Wang XL, Wilcken DEL: Angiotensin converting enzyme genotype in children and coronary events in their grandparents. Circulation 1995;91:1655-1658.
26. Ludwig E, Corneli PS, Anderson JL, Mashall HW, Lalouel JM, Ward RH: Angiotensin converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995;91:2120-2124.
27. Keavney BD, Dudley CRK, Stratton IM, Holman RR, Matthew DR, Ratcliffe PJ, Turner RC: UK Prospective Diabetes Study (UKPDS) 14: Association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM. Diabetologia 1995;38:948-952.
28. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Boelskifte S, Borch-Johnson K, Parving HH: Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 1995; 38:798-803.
29. Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamaguchi A, Kubo H, Kawaguchi Y, Kon V, Matsuoka K, Ichikawa I, Sakai O: Angiotensin I converting enzyme gene polymorphism in non-insulin-dependent diabetes mellitus. Kidney Int 1996;50:657-664.
30. Doi Y, Yoshizumi M, lino K, Yamamoto M, Ichikawa K, Iwase M, Fujishima M: Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996;39:97-102.
31. Ohno T, Kawazu S, Tomono S: Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism 1996: 45:218-222.
32. Fujisawa T, Ikegami H, Shen GQ, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Rakugi H, Higaki J, Ohishi M, Fuji K, Fukuda M, Ogihara T: Angiotensin-I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995;18:983-985.
33. Schmidt S, Schone N, Ritz E, the Diabetic Nephropathy Study Group: Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 1995;47:1176-1181.
34. Mizuiri S, Hemmi H, Inoue A, Yoshikawa H, Tanegashima M, Fushimi T, Ishigami M, Amagasaki Y, Ohara T, Shimatake H, Hasegawa A: Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995;70:455-459.
35. Earle K, Walker J, Hill C, Viberti GC: Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1992;326:673-677.
36. Jeunemaitre X, Soubrier F, Kotelevtsev Y, Lifton R, Williams C, Charru A, Hunt S, Hopkins P, Williams R, Lalouel JM, Corvol P: Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992;71:169-180.
37. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJL: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994;330:1629-1633.
38. Viberti GC, Keen H, Wiseman MJ: Raised arterial pressure in parents of proteinuric insulin-dependent diabetes. BMJ 1987;295:515-517.
39. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, Lecerf O, Poirier O, Parving HH: Angiotensinogen gene polymorphism in IDDM patients with diabetic nephropathy. Diabetes 1996;45:367-369.
40. Doria A, Onuma T, Gearin G, Freire MBS, Warram JH, Krolewski AS: Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes. Hypertension 1996;27:1134-1139.
41. Fogerty DG, Haron JC, Hughes AE, Nevin NC, Doherty CC, Maxwell AP: A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 1996;45:1204-1208.
42. Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski AS: Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q. Diabetes 1998;47:1164-1169.